Qingdao Haier Biomedical Co.,Ltd

XSSC:688139 Stock Report

Market Cap: CN¥10.5b

Qingdao Haier BiomedicalLtd Balance Sheet Health

Financial Health criteria checks 5/6

Qingdao Haier BiomedicalLtd has a total shareholder equity of CN¥4.5B and total debt of CN¥19.1M, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are CN¥5.6B and CN¥1.1B respectively. Qingdao Haier BiomedicalLtd's EBIT is CN¥290.7M making its interest coverage ratio -4. It has cash and short-term investments of CN¥1.8B.

Key information

0.4%

Debt to equity ratio

CN¥19.10m

Debt

Interest coverage ratio-4x
CashCN¥1.85b
EquityCN¥4.54b
Total liabilitiesCN¥1.10b
Total assetsCN¥5.64b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 688139's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥948.8M).

Long Term Liabilities: 688139's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥151.4M).


Debt to Equity History and Analysis

Debt Level: 688139 has more cash than its total debt.

Reducing Debt: 688139's debt to equity ratio has increased from 0.08% to 0.4% over the past 5 years.

Debt Coverage: 688139's debt is well covered by operating cash flow (1025%).

Interest Coverage: 688139 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies